Prediction of Outcome to Neoadjuvant Therapy in Non-small Cell Lung Cancer（NSCLC）
Recruiting · NCT07388771 · Observational (researchers observe without assigning treatment) · Lead sponsor: Qian Chu
View the official record on ClinicalTrials.gov →What this trial is about
This observational study aims to construct and validate the performance of a multimodal predictive model in forecasting the outcomes of neoadjuvant therapy in patients with NSCLC. The core research question is: Can a multi-model approach predict outcomes of neoadjuvant therapy for non-small cell lung cancer and provide clinical recommendations?
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- pathologically diagnosed non-small cell lung cancer
- The treatment plan is：receiving neoadjuvant chemo-immunotherapy during the study period, followed by surgical resection
Exclusion criteria
- recurrent or metastatic lung cancer;
- patients with other primary tumors
Where it is running
2 locations listed.
- Tongji hospital - Wuhan, Hubei, China
- Sir Run Run Shaw Hospital - Hangzhou, Zhejiang, China